Hematology/Oncology

Top Story

VIDEO: Entospletinib shows promise for advanced lymphoma

June 22, 2017

CHICAGO — Entospletinib appeared safe for patients with relapsed or refractory lymphoplasmacytoid lymphoma, according to study results presented at the ASCO Annual Meeting.

In the Journals PlusPerspective

First-line nivolumab fails to extend PFS in non–small cell lung cancer

June 21, 2017
Nivolumab did not result in longer PFS than platinum-based chemotherapy as first-line treatment for stage IV or recurrent non–small cell lung cancer in patients…

AMA supports efforts to improve substance abuse disorder coverage

June 21, 2017
Experts from four leading nonprofits in the addiction field have determined that existing legislation does not adequately protect insurance coverage of substance abuse…
FDA News

FDA commissioner calls for public input on lifting generic barriers

June 21, 2017
In introducing the FDA’s Drug Competition Action Plan, the commissioner announced his intent to assess ways FDA rules may be misused to create obstacles against…
Meeting News

Guest Commentary: STAMPEDE trial provides exciting results, questions in prostate cancer treatment

June 21, 2017
In this guest commentary, Terence Friedlander, MD, discusses the benefits associated with the addition of
More News Headlines »
CME

Bridging the Gap from Knowledge to Practice in CRPC

This activity is supported by educational funding provided by AbbVie Inc.; Astellas Scientific and Medical Affairs, Inc. and Medivation; and Sanofi US.

The selection of therapy for patients with castration-resistant prostate cancer (CRPC) remains challenging. Review…
More »
Video
Meeting News

VIDEO: Speaker discusses how studies may impact future of gynecologic oncology

June 17, 2017
More »
Featured
ASCO Annual Meeting

ASCO Annual Meeting

CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement